OPCH
Option Care Health, Inc.
-0.45 (-1.84%)24.02USD936K成交股數3.8B市值18.8本益比(近四季)0.7股價營收比+1.3%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 | 22Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.4B+0% | 1.4B+12% | 1.4B+15% | 1.3B+16% | 1.3B+23% | 1.3B+20% | 1.2B+21% | 1.1B+20% | 1.1B | 1.1B | 1.0B | 952M |
| 營業成本 | 1.1B | 1.2B | 1.1B | 1.1B | 1.1B | 1.0B | 978M | 908M | 839M | 818M | 787M | 796M |
| 毛利 | 262M-2% | 273M+6% | 269M+8% | 263M+10% | 268M+6% | 257M+2% | 249M+9% | 239M+3% | 254M | 251M | 229M | 231M |
| 毛利率 | 19.4% | 19.0% | 19.0% | 19.7% | 19.9% | 20.1% | 20.3% | 20.8% | 23.3% | 23.5% | 22.5% | 24.3% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 175M | 172M | 170M | 168M | 165M | 157M | 154M | 155M | 158M | 154M | 148M | 148M |
| 營業利益 | 72.5M-17% | 84.5M-1% | 82.7M+3% | 79.2M+15% | 87.0M+7% | 85.1M+3% | 80.7M+21% | 69.0M+1% | 81.0M | 82.4M | 66.6M | 68.2M |
| 營業利益率 | 5.4% | 5.9% | 5.8% | 5.9% | 6.5% | 6.7% | 6.6% | 6.0% | 7.4% | 7.7% | 6.6% | 7.2% |
| 稅後淨利 | 45.3M-25% | 51.8M-4% | 50.5M-5% | 46.7M+4% | 60.1M+7% | 53.9M-53% | 53.0M+35% | 44.8M-6% | 56.3M | 114M | 39.2M | 47.6M |
| 淨利率 | 3.4% | 3.6% | 3.6% | 3.5% | 4.5% | 4.2% | 4.3% | 3.9% | 5.2% | 10.7% | 3.9% | 5.0% |
| 稀釋 EPS | 0.29-19% | 0.32+3% | 0.31+3% | 0.28+8% | 0.36+16% | 0.31-51% | 0.30+43% | 0.260% | 0.31 | 0.63 | 0.21 | 0.26 |
| 稀釋股數 | 158M | 163M | 164M | 167M | 173M | 172M | 174M | 176M | 181M | 181M | 183M | 182M |
資產負債表 期末餘額
| 科目 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 | 22Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 177M | 310M | 199M | 171M | 413M | 483M | 377M | 220M | 386M | 441M | 298M | 294M |
| 應收帳款 | 516M | 475M | 481M | 477M | 410M | 429M | 468M | 574M | 383M | 397M | 395M | 378M |
| 存貨 | 416M | 416M | 404M | 369M | 388M | 311M | 281M | 242M | 251M | 263M | 250M | 224M |
| 總資產 | 3.4B | 3.5B | 3.4B | 3.3B | 3.4B | 3.4B | 3.3B | 3.2B | 3.2B | 3.3B | 3.1B | 3.1B |
| 有息負債 | 1.2B | 1.2B | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B |
| 總負債 | 2.0B | 2.1B | 2.0B | 2.0B | 2.0B | 2.0B | 1.9B | 1.8B | 1.8B | 1.8B | 1.8B | 1.7B |
| 股東權益 | 1.4B | 1.4B | 1.4B | 1.4B | 1.4B | 1.4B | 1.4B | 1.4B | 1.4B | 1.5B | 1.4B | 1.4B |
| 負債比 | 60.0% | 61.0% | 59.8% | 59.2% | 59.0% | 58.4% | 57.9% | 56.0% | 55.6% | 55.6% | 56.9% | 55.5% |
| 淨現金(現金 − 有息負債) | −976M | −845M | −905M | −933M | −692M | −622M | −729M | −837M | −671M | −616M | −760M | −764M |
現金流量表 單季
| 科目 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 | 22Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −12.1M | – | – | −7.2M-90% | – | – | – | −68.8M | – | – | 89.8M | – |
| 資本支出 | 9.0M | – | – | 9.4M | – | – | – | 5.8M | – | – | 5.8M | – |
| 自由現金流 | −21.2M | – | – | −16.6M-78% | – | – | – | −74.6M | – | – | 84.0M | – |
| 折舊攤銷 | 14.9M | 16.3M | 16.2M | 15.7M | 16.6M | 14.7M | 14.9M | 14.7M | 15.0M | 14.9M | 14.5M | 14.5M |
| 買回庫藏股 | – | – | – | – | – | – | – | 40.1M | – | – | 75.0M | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | -1.6% | – | – | -1.2% | – | – | – | -6.5% | – | – | 8.3% | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 5.6B
| Reportable | 5.6B | 100.0% | +13.1% |
|---|
主要客戶2025 年度 · 5.6B
| Commercial Customer | 4.9B | 86.8% | +12.7% |
|---|---|---|---|
| Government Customer | 682M | 12.1% | +16.7% |
| Patient Customer | 65.5M | 1.2% | +0.9% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 5.6B | +13.0% | 208M | 3.7% | 1.27 | 217M |
| FY2024 | 5.0B | +16.2% | 212M | 4.2% | 1.23 | 288M |
| FY2023 | 4.3B | +11.2% | 267M | 6.2% | 1.48 | 329M |
| FY2022 | 3.9B | +12.5% | 151M | 3.9% | 0.83 | 232M |
| FY2021 | 3.4B | +13.4% | 140M | 4.1% | 0.77 | 183M |
| FY2020 | 3.0B | +31.3% | −8.1M | -0.3% | -0.04 | 101M |
| FY2019 | 2.3B | +19.1% | −75.9M | -3.3% | -0.49 | 11.2M |
| FY2018 | 1.9B | – | −6.1M | -0.3% | -0.04 | −1.8M |